Bangkok Dusit Medical Services Public Company Limited
BDULFOTCHealthcare● Active
$0.56
$-0.00(-0.88%)
Market Cap$8.8B
P/E Ratio—
52W High$0.71
52W Low$0.5551
Bangkok Dusit Medical Services Public Company Limited (BDULF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BDULF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
$0.01
Revenue
$0.86B
Est. $0.86B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
BDULF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 12, 2026 | — | $0.01 | — | $0.86B | $0.86B | +0.1% |
| — Q1 FY2026 | Feb 24, 2026 | — | $0.01 | — | $0.90B | $0.91B | -1.2% |
| — Q3 FY2025 | Aug 13, 2025 | — | $0.01 | — | $0.82B | $0.87B | -5.8% |
| — Q2 FY2025 | May 12, 2025 | — | $0.01 | — | $0.81B | — | — |
| — Q1 FY2025 | Feb 26, 2025 | — | $0.01 | — | $0.80B | $0.81B | -1.2% |
| — Q4 FY2024 | Nov 12, 2024 | — | $0.01 | — | $0.84B | — | — |
| — Q3 FY2024 | Aug 13, 2024 | — | $0.01 | — | $0.70B | — | — |
| — Q2 FY2024 | May 14, 2024 | — | $0.01 | — | $0.73B | — | — |
Q2 FY2026
May 12, 2026
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.86B
Q1 FY2026
Feb 24, 2026
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.90B
Q3 FY2025
Aug 13, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.82B
Q2 FY2025
May 12, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.81B
Q1 FY2025
Feb 26, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.80B
Q4 FY2024
Nov 12, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.84B
Q3 FY2024
Aug 13, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.70B
Q2 FY2024
May 14, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.73B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $28.0B | $28.2B | $28.4B | 4 |
| Q4 FY2025 | $28.3B | $28.8B | $29.4B | 5 |
| Q3 FY2025 | $27.9B | $28.3B | $28.5B | 3 |
| Q2 FY2025 | $28.3B | $28.3B | $28.3B | 1 |
| Q1 FY2025 | $28.1B | $28.2B | $28.2B | 2 |
| Q4 FY2024 | $27.3B | $27.6B | $27.9B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 12, 2026 | — | $0.66 | $0.66 | +0.00% |
| — Q1 FY2026 | Feb 24, 2026 | — | $0.65 | $0.65 | -0.02% |
| — Q3 FY2025 | Aug 13, 2025 | — | $0.61 | $0.61 | +0.00% |
| — Q2 FY2025 | May 12, 2025 | — | $0.71 | $0.71 | +0.00% |
| — Q1 FY2025 | Feb 26, 2025 | — | $0.66 | $0.66 | +0.00% |
| — Q4 FY2024 | Nov 12, 2024 | — | $0.85 | $0.85 | +0.00% |
| — Q3 FY2024 | Aug 13, 2024 | — | $0.73 | $0.73 | +0.62% |
| — Q2 FY2024 | May 14, 2024 | — | No price data | $0.73 | — |
Q2 FY2026+0.00%
Report Date
May 12, 2026
EPS Beat/Miss
—
Price Before
$0.66
Price After
$0.66
Q1 FY2026-0.02%
Report Date
Feb 24, 2026
EPS Beat/Miss
—
Price Before
$0.65
Price After
$0.65
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
—
Price Before
$0.61
Price After
$0.61
Q2 FY2025+0.00%
Report Date
May 12, 2025
EPS Beat/Miss
—
Price Before
$0.71
Price After
$0.71
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
—
Price Before
$0.66
Price After
$0.66
Q4 FY2024+0.00%
Report Date
Nov 12, 2024
EPS Beat/Miss
—
Price Before
$0.85
Price After
$0.85
Q3 FY2024+0.62%
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$0.73
Price After
$0.73
Q2 FY2024—
Report Date
May 14, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.73
Beat Rate0 / 8 quarters
Largest Move+0.62% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BDULF ends December
Bangkok Dusit Medical Services Public Company Limited (BDULF) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $0.01 (in line with the analyst consensus of —). The next BDULF earnings date is expected around September 1, 2026.
Each quarter, investors track BDULF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BDULF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BDULF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BDULF earnings · 4 questionsBangkok Dusit Medical Services Public Company Limited's next earnings report is expected around September 1, 2026. BDULF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BDULF historically reports after market close (AMC).
BDULF earnings datewhen is BDULF earningsBDULF next earnings datewhen does BDULF report earningsBDULF earnings calendar
▸ Source: FMP · Bangkok Dusit Medical Services Public Company Limited SEC filings · US GAAP · Bangkok Dusit Medical Services Public Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026